* Entered into a share transfer agreement with Jiaxing Yun Shi Tai Yu Investment Partnership​

* ‍Company has agreed to sell its entire 20% equity stake in Tianjin Sinobioway Biomedicine Co​

* Proposed disposal not expected to have material impact on co's earnings per share for current fy

* ‍Deal for a cash consideration of rmb47.8 million Source text for Eikon: Further company coverage: